zopiclone has been researched along with Anxiety Disorders in 6 studies
zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.
Anxiety Disorders: Persistent and disabling ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Triazolam-treated patients presented significantly more day-time-interdose anxiety than zopiclone as assessed by the weekly HARS and Clinical Global Assessment of Anxiety." | 2.67 | Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. ( Beauclair, L; Beaudry, P; Chouinard, G; Fontaine, R; Le Morvan, P, 1990) |
| " The recommended dosing to improve sleep onset and/or maintenance is 2mg or 3mg for adult patients (aged 18-64 years) and 2mg for older adult patients (aged > or =65 years)." | 2.43 | Eszopiclone: esopiclone, estorra, S-zopiclone, zopiclone--Sepracor. ( , 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kassam, A | 1 |
| Carter, B | 1 |
| Patten, SB | 1 |
| Harter, C | 1 |
| Piffl-Boniolo, E | 1 |
| Rave-Schwank, M | 1 |
| Fontaine, R | 1 |
| Beaudry, P | 1 |
| Le Morvan, P | 1 |
| Beauclair, L | 1 |
| Chouinard, G | 1 |
| Agnoli, A | 1 |
| Manna, V | 1 |
| Martucci, N | 1 |
| Julou, L | 1 |
| Blanchard, JC | 1 |
| Dreyfus, JF | 1 |
1 review available for zopiclone and Anxiety Disorders
| Article | Year |
|---|---|
Eszopiclone: esopiclone, estorra, S-zopiclone, zopiclone--Sepracor.
Topics: Anxiety Disorders; Azabicyclo Compounds; Clinical Trials, Phase III as Topic; Drugs, Investigational | 2005 |
2 trials available for zopiclone and Anxiety Disorders
| Article | Year |
|---|---|
Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety.
Topics: Adult; Anxiety Disorders; Azabicyclo Compounds; Drug Administration Schedule; Female; Humans; Hypnot | 1990 |
Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia.
Topics: Adult; Anxiety Disorders; Azabicyclo Compounds; Chronic Disease; Clinical Trials as Topic; Double-Bl | 1989 |
3 other studies available for zopiclone and Anxiety Disorders
| Article | Year |
|---|---|
Sedative hypnotic use in Alberta.
Topics: Acetamides; Adolescent; Adult; Anxiety Disorders; Azabicyclo Compounds; Canada; Catchment Area, Heal | 2006 |
[Development of drug withdrawal delirium after dependence on zolpidem and zoplicone].
Topics: Anxiety Disorders; Azabicyclo Compounds; Drug Therapy, Combination; Female; Humans; Hypnotics and Se | 1999 |
Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone.
Topics: Aggression; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Azabicyclo Compounds; | 1985 |